| [1] |
ZHANG Qing, ZHU Lei, LIN Cunlian, XIE Peitao, YANG Junli, SU Changhai.
Psoriasis aggravated by labetalol during pregnancy: a case report
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1060-1063.
|
| [2] |
ZHENG Li, ZHANG Xuqian, SUN Xuelin, DING Huihua.
Effect and safety of sacubatril/valsartan sodium in the treatment of hypertension: a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1118-1122.
|
| [3] |
HU Xiao-le，LI Hui-en，LI Bin，WANG En-li，FENG Zhong，ZHAO Tao*.
Experimental Study on the Long-term Toxicity of Isosorbide Mononitrate and Ivabradine Hydrochloride Compound in Beagle Dogs
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(2): 65-68.
|
| [4] |
LI Xin, LI Bin, ZHAO Tao, MOU Li-li, FENG Zhong, YAO Jing-chun.
Experimental Study on Long-term Toxicity of ISMN Valsartan Spironolactone Antihypertensive Compound in Rats
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(8): 457-461.
|
| [5] |
LIN Xiao-ming, WEI Bao-han, ZENG Yi, WEI Ping-yuan, LIANG Han-qin, XIE Wei-qian, CHEN Ming-zhong.
Study on Compatible Stability of Nitroprusside Sodium for Injection with Sodium Chloride Injection
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(6): 369-372.
|
| [6] |
ZHONG Xue, ZHANG Ya-tong, HU Xin ,CHENG Gang.
Pharmaceutical Care of One Patient with Suspected Secondary Hypertension
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(2): 119-121.
|
| [7] |
WANG Yi-yang, WANG Yi-fan, GAO Zhen-ying.
A Clinical Study of the Adverse Drug Reactions of Bisoprolol
[J]. Chinese Journal of Pharmacovigilance, 2011, 8(9): 515-517.
|
